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A B S T R A C T
Background: Amajor clinical problem relating to hernia repair is the formation of intra-abdominal, post-
surgical adhesions when mesh products are used to reinforce the abdominal wall. To achieve better
outcomes, more technologically-advanced products designed to achieve permanence of repair while elimi-
nating serious complications such as adhesion formation are needed. This study was designed to assess
the histological remodeling and adhesiogenic properties of the Zenapro™ Hybrid Hernia Repair Device
as compared to uncoated and coated polypropylene.
Materials and Methods: Zenapro™, Prolene® and Ventralight® ST Mesh were implanted to repair full-
thickness abdominal wall defects in rabbits and rats and were allowed to survive for various lengths of
time. Animals were euthanized, the implants were identiﬁed, and the extent and tenacity of adhesions
were evaluated. Tissue samples were collected and evaluated for inﬂammation, integration of the mesh
with the abdominal wall, and collagen deposition.
Results: A signiﬁcant difference was found in the extent of adhesions in the Prolene group as com-
pared to the Zenapro group (p = 0.021) and the Ventralight ST group (p = 0.04) in the rat study. The tenacity
of the adhesions in the Prolene mesh group trended higher than in the other groups but failed to reach
statistical signiﬁcance. Histological evaluation demonstrated that collagen accumulation was greatest for
the Zenapro implants as compared to either the Ventralight ST or Prolene samples. At the conclusion of
6-months in the rabbit model, the Zenapro sites showed signs of a thicker repair composed of more or-
ganized mature collagen than was seen in the Ventralight ST samples. Neither device was found to elicit
any sort of detrimental inﬂammatory tissue reaction.
Conclusion: A combination hernia device composed of a complete extracellular matrix with a synthet-
ic mesh can result in enhanced tissue ingrowth and neovascularization while maintaining high tensile
strength and mitigating adhesiogenic effects.
© 2016 The Authors. Published by Elsevier Ltd on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Over the last 75 years, hernia repair surgery has moved from
primary closure with suture alone to the use of mesh to achieve
successful, prolonged outcomes. Mesh reinforcement has more re-
cently evolved as complexmaterials have been developed to include
a selection of a wide range of synthetic, biologic, or combination
mesh products, each with their own advantages and disadvantages.
Surgical debate continues to precisely deﬁne the typical char-
acteristics of the optimal hernia mesh; however it is generally agreed
that the ideal prosthetic material should be nontoxic, biocompatible,
and effective in minimizing postoperative adhesions. The mesh
should allow for repair of the primary fascial defect, integrating
into the surrounding tissue while maintaining high tensile strength
and low adhesion development. It should also allow for tissue in-
growth, neoperitoneum formation, and neovascularization without
interfering with the normal healing process [1]. Currently-available
products struggle to meet these needs. To achieve best outcomes
for patients, newer andmore technologically-advanced products de-
signed to achieve permanence of repair while eliminating serious
complications such as erosion, infection, chronic inﬂammation or
adhesion formation are needed.
To prevent adhesions, preservation of the parietal peritoneum
during hernia repair has been suggested because it forms a barrier
between the viscera and the mesh [2]. However, in daily practice,
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it is sometimes not feasible to preserve the parietal peritoneum in
order to protect the abdominal contents from the direct contact with
the mesh. Additionally, the advent of laparoscopic hernia repairs
and various intraperitoneal onlay mesh (IPOM) procedures require
that mesh come in contact with the bowel.
While commonly used synthetic materials, such as polypropyl-
ene, are inexpensive, they can be attributed to many serious adverse
events and are still considered relatively contraindicated for use in
contaminated and infected settings because surgical removal is often
necessary if chronic infection occurs. Synthetic mesh materials are
prone to chronic inﬂammation and erosion, and often cause exten-
sive adhesion formation when placed directly in contact with the
bowel and visceral organs [3].
Commonly used biologic materials, such as porcine dermis or
small intestinal submucosa, while more expensive than synthetic
mesh, are often touted as a template for rapid remodeling and col-
lagen deposition by the patient, leading to a naturally-stable outcome.
These materials are susceptible to rapid degradation by some bac-
terial collagenases in contaminated or dirty ﬁelds, but are also less
prone to erosion and chronic inﬂammation than are synthetics, and
have been shown to have the added beneﬁt of being relatively less
adhesiogenic than their synthetic counterparts [4,5].
To combat the complications associated with purely synthetic
or biologic materials, products containing synthetic materials coated
with biologically-friendly components have been developed. These
products typically utilize a synthetic mesh that has been coated with
an extracellular matrix component as a means of improving the
tissue-compatibility of the synthetic polymer.
Newer devices, however, combine the complete extracellular
matrix (ECM) found in a biologic device with a polymer core of syn-
thetic mesh. The currently available device, Zenapro™ Hybrid Hernia
Repair Device (Cook® Medical, Bloomington, IN, USA), is com-
posed of a medium-weight polypropylene core embedded in a
multilaminate structure of porcine small intestinal submucosa (SIS),
a naturally-occurring ECM that has a long and extensive history of
use in multiple human clinical applications, including hernia repair.
The main aim of the current animal studies was to demon-
strate the histological remodeling and adhesiogenic properties of
the Zenapro Hybrid Hernia Repair Device and compare it to un-
coated (Prolene®, Ethicon) and coated (Ventralight® ST mesh, C.R.
Bard, Inc.) polypropylene.
2. Materials and methods
2.1. Animals
A total of twenty-four (24) Sprague–Dawley rats weighing ap-
proximately 200–300 g and six (6) female New ZealandWhite (NZW)
rabbits (Covance, Inc., Indianapolis, IN) weighing 3.5–4.0 kg were
used to evaluate the adhesiogenic properties and histological re-
modeling of the Zenapro and Ventralight ST devices. Additionally,
the adhesiogenic properties and histological remodeling of un-
coated polypropylene were also studied in the rat model.
The minimum number of animals deemed necessary to evalu-
ate adhesiogenesis and remodeling were utilized. All animals were
randomly assigned to treatment groups. Theywere housed in a light-
controlled environment in separate cages maintained at 22 ± 1 °C,
were fed a high-ﬁber diet and water ad libitum, and were under vet-
erinary care throughout the study. All procedures were performed
following institutional animal care and use committee approval.
2.2. Test samples
Test devices (3 × 3 cm for rabbits, 2 × 2 cm for rats) of the Zenapro
Hybrid Hernia Repair Device were manufactured speciﬁcally for this
study. Brieﬂy, the Zenapro device conﬁguration consisted of 4 layers
of SIS, 1 layer polypropylene, and 2 additional layers of SIS, all of
which were vacuum press-laminated together in a ﬁnal stacked con-
ﬁguration. The test devices were sterilized with ethylene oxide and
were implanted as underlays such that the surface containing 4 layers
of SIS was oriented closest to the abdominal viscera.
Prolene® and Ventralight® STMeshwere obtained in ﬁnal package
form from a commercial distributor. While Prolene is composed of
uncoated knitted polypropylenemonoﬁlament, Ventralight STMesh
consists of knitted polypropylene and polyglycolic acid (PGA). A
bioresorbable hydrogel coating comprising sodium hyaluronate (HA),
carboxymethylcellulose (CMC), and polyethylene glycol (PEG), col-
lectively known as Sepra® technology, is adhered adjacent to the
PGA layer. The Sepra coating is designed to resorb over 30 days and
provide a temporary adhesion barrier to the polypropylene layer
so as to protect the viscera. Test devices (3 × 3 cm for rabbits, 2 × 2 cm
for rats) were cut from larger, sterile mesh sheets just prior to being
surgically implanted into the animals.
2.3. Implant surgery
Each rat was anesthetized with an intraperitoneal injection of
ketamine (80 mg/kg) and xylazine (10 mg/kg). Following anesthet-
ic induction, a midline incision was created along the abdomen. The
abdominal fascia was exposed and a 2 × 2 cm defect was made in
the abdominal fascia and muscle tissue planes, exposing the ab-
dominal viscera. A 2 × 2 cm Zenapro device, Ventralight ST mesh,
or Prolene mesh, was placed as an underlay beneath the full-
thickness defect and secured with nylon suture to the adjacent
muscle tissue plane. Silk suture was used to close the subcutane-
ous tissue plane. The dermal ﬂaps were re-approximated and the
midline incision was closed. A total of eight (8) rats were im-
planted with each device. Animals were recovered from anesthesia
and were carefully monitored by the animal care team at the Uni-
versity of Notre Dame for the duration of the study.
Each rabbit was anesthetized with a mixture of 35 mg/kg
ketamine and 5 mg/kg xylazine given via intramuscular injection.
Isoﬂurane was administered by mask to maintain a surgical plane
of anesthesia. Following anesthetic induction, a midline incision was
created along the abdomen. On either side of the midline, an ap-
proximately 2 cm wide full-thickness defect was created bilaterally
by cutting through the abdominal fascia and muscle tissue planes,
exposing the abdominal viscera. A 3 × 3 cm Zenapro device (right-
hand side) and Ventralight ST device (left-hand side) were placed
as underlays beneath the full-thickness defects and secured with
nylon suture to the adjacent muscle tissue plane. Silk suture was
used to close the subcutaneous tissue plane. The dermal ﬂaps were
re-approximated and the midline incision was closed. A total of six
(6) rabbits were implanted with each device. Animals were recov-
ered from anesthesia and were carefully monitored by the animal
care team for the duration of the study.
2.4. Explant surgery
Rats were euthanized after 3 weeks and rabbits were euthan-
ized after 6 weeks, 3 months, or 6 months. Rats were euthanized
using an overdose inhalation of CO2, and rabbits were humanely eu-
thanized using a combination of ketamine (25mg/kg), acepromazine
(2.5 mg/kg), and xylazine (5 mg/kg), followed by direct cardiac in-
jection of 3 mL of Euthasol® (pentobarbital sodium and phenytoin
sodium). Upon conﬁrmation of cardiac arrest, an incisionwas created
through the abdominal dermis midline. The implants were iden-
tiﬁed and the extent and tenacity of adhesions were evaluated using
a scale adapted from similar studies of adhesiogenesis (Table 1). Ad-
hesion tenacity was regarded as the resistance of the tissue to
separation, and adhesion extent was regarded as the degree to which
the adhesion tissue covered the explanted device. Tissue samples
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were placed in 10% neutral buffered formalin for ﬁxation prior to
sectioning and staining with hematoxylin and eosin for microscop-
ic evaluation.
2.5. Statistical analysis
A one-tailed paired t-test was performed in the rat study to assess
differences in the extent and tenacity of adhesions across the ex-
perimental groups. Due to the small numbers of rabbits utilized in
the study, no statistical analysis was performed on the rabbit data.
3. Results
3.1. Clinical evaluation
Surgery, anesthesia, and recovery were uneventful in all animals
and all survived to their predetermined sacriﬁce date and were ana-
lyzed. All rats and rabbits showed normal eating, drinking, urination,
and bowel movement habits throughout the course of the study and
either maintained or gained weight during the study. No adverse
events, hernia formation or bulging of the abdominal wall were
observed.
3.2. Gross pathology
All implants were incorporated into the surrounding tissues and
appeared continuous with the surrounding body wall in both the
rats and the rabbits.
In the rat study, subcutaneous tissue and overlying skin were
loosely adhered to the Ventralight ST and Zenapro implants and no
visceral attachments were seen. Comparatively, the uncoated Prolene
mesh had the highest scores for adhesion extent and tenacity. There
was a signiﬁcant difference in the extent of adhesions in the Prolene
group as compared to the Zenapro group (p = 0.021) and the
Ventralight ST group (p = 0.04) (Table 2). The tenacity of the adhesions
in the Prolene mesh group trended higher than in the other groups
but failed to reach statistical signiﬁcance.
In the latter time points of the rabbit study, the Zenapro-
repaired sites showed thicker collagenous tissue as compared to the
Ventralight ST repaired sites. The subcutaneous tissue and overly-
ing skin were loosely adhered to the Ventralight ST and Zenapro
implants, and both device conﬁgurations elicited some small vis-
ceral adhesions, but the extent of the adhesions to the devices (i.e.,
percent surface area of coverage) was minor in scope (Table 3) and
mostly directed at the suture ﬁxation points.
3.3. Histologic ﬁndings
In the rat study, histological analysis demonstrated that the
Zenapro implants performedwell with signiﬁcant ﬁbrovascular tissue
ingrowth, little inﬂammation immediately adjacent to the propyl-
ene ﬁbers, and remnant SIS undergoing active remodeling (Fig. 1).
Ventralight ST implants had signiﬁcant tissue deposition that in-
cluded both inﬂammatory cells and ﬁbrovascular deposition, with
the inﬂammatory component directed primarily toward the
adhesion-resistant coating (cross-linked hyaluronic acid) (Fig. 2).
Prolene devices demonstrated only minimal amounts of tissue
deposition with some inﬂammation immediately around the
polypropylene ﬁbers; evidence of adhesions was present in most
samples (Fig. 3). Trichrome staining suggested that the collagen
Table 1
Adhesion grading scale.
Score Characteristic
Extent 0 No adhesions
1 Adhesions on up to 25% of the explant
2 Adhesions on up to 50% of the explant
3 Adhesions on up to 75% of the explant
4 Adhesions on up to 100% of the explant
Tenacity 0 No resistance to separation
1 Mild (ﬁlmy), easily separated
2 Moderate resistance to separation
3 Marked resistance to separation
4 Sharp dissection required for separation
Table 2
Extent and tenacity of adhesions in the rat model.
Rat no. Adhesions
Zenapro Ventralight Prolene
Extent Tenacity Extent Tenacity Extent Tenacity
1 1 2 0 0 3 3
2 1 2 0 0 4 4
3 1 2 1 2 2 2
4 0 0 3 3 4 3
5 1 1 1 2 2 2
6 1 2 3 3 4 3
7 2 2 2 2 0 0
8 0 0 0 0 1 1
Mean ± SD 0.9 ± 0.6* 1.4 ± 0.9 1.3 ± 1.3** 1.5 ± 1.3 2.5 ± 1.5 2.3 ± 1.3
* p = 0.021 vs. Prolene.
** p = 0.04 vs. Prolene.
Table 3
Extent and tenacity of adhesions in the rabbit model.
Rabbit no. Implant duration Adhesions
Zenapro Ventralight
Extent Tenacity Extent Tenacity
1 6 weeks 1 1 1 1
2 3 months 1 2 1 2
3 3 months 0 0 0 0
4 6 months 0 0 2 3
5 6 months 0 0 0 0
6 6 months 1 4 0 0
Fig. 1. Tissue response to Zenapro in the rat after 3 weeks. Histological (H&E) anal-
ysis demonstrates signiﬁcant ﬁbrovascular tissue ingrowth, minimal inﬂammation
immediately adjacent to the propylene ﬁbers, and remnant SIS undergoing active
remodeling. Bar = 100 μm.
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accumulation was greatest for the Zenapro implants as compared
to either the Ventralight ST or Prolene samples (Fig. 4).
The rabbit study assessed the tissue repair proﬁles of Zenapro
and Ventralight ST over time. Relative to the Ventralight repair, the
Zenapro device supported a more robust early ﬁbrovascular repair
which was dominated by an intense cellular inﬁltration into the
repair site at 6 weeks. By 3 months, the Zenapro repair site was in
a state of transition that was characterized by the progressive de-
position and organization of neocollagenous tissue. At the conclusion
of 6-months, the Zenapro sites showed signs of a thicker repair com-
prisingmore extensive and organizedmature collagen thanwas seen
in the Ventralight ST samples (Fig. 5 and Fig. 6). Throughout the study,
neither device was found to elicit any sort of detrimental inﬂam-
matory tissue reaction, even though both devices had minor issues
with adhesion formation, which was localized to the suture ﬁxa-
tion points.
4. Discussion
A major clinical problem relating to hernia repair is the forma-
tion of intra-abdominal, post-surgical adhesions. A dynamic process
that begins at the time of surgical incision and includes the for-
mation of ﬁbrinous exudate, cytokine production, cell migration,
edema, and suppression of ﬁbrinolytic activity, adhesion forma-
tion presents a potential problem following any laparotomy [6], but
is a particular challenge when foreign materials are placed in the
abdomen at the time of hernia repair.
In a study of patients in Scotland, one in three patients with ab-
dominal or pelvic operations was readmitted over 10 years and 1
in 18 of these was due to adhesions [7]. In the US, the 2005 Health-
care Cost and Utilization Project’s Nationwide Inpatient Sample was
used to determine that $2.3 billion was spent on inpatient care at-
tributed to adhesiolysis-related procedures [8]. Clearly, the patient
morbidity and associated costs with the formation of adhesions after
abdominal wall surgery warrant research and development efforts
targeted at creating medical devices that are less adhesiogenic. The
current study was performed to assess how the Zenapro Hybrid
Hernia Repair Device compared with respect to adhesion forma-
tion to an uncoated polypropylene mesh and an adhesion-resistant
coated hernia mesh in animal models of abdominal hernia repair.
One reason adhesions form is as a foreign body response to syn-
thetic meshes; one approach to decreasing adhesions is to block this
response. Several products are available that have an inert coating
on the mesh to “hide” the plastic. One such coating is sodium hy-
aluronate (HA), carboxymethylcellulose (CMC), and polyethylene
glycol (PEG), collectively known as Sepra® technology. The Sepra tech-
nology alone (Sepraﬁlm®) has been shown in preclinical models to
reduce adhesions [9]. Clinically, there is some evidence that Sepraﬁlm
reduces the incidence of reoperations for adhesive small bowel ob-
struction [10]. Ventralight has become available for clinical use more
recently and consequently, there is less documentation. However,
a prospective study followed 61 patients an average of 23 months
after laparoscopic ventral hernia repair with the Ventralight ST hernia
patch and found a low incidence of adverse events (8%) at ﬁnal
follow-up [11].
An alternative approach to “hiding” the synthetic under an anti-
adhesive coating is to insert it between layers of a complete ECM,
thus creating a true synthetic:biologic hybrid. One advantage to this
approach is that the active tissue induction and remodeling induced
by the biologic material result in organized and strong tissue de-
position instead of scar tissue formation over time.
The Zenapro Hybrid Hernia Repair Device is the ﬁrst device avail-
able that contains both a synthetic component, medium-weight open
pore polypropylene, and a complete ECM, porcine small intestinal
submucosa (SIS). SIS has been shown in previous studies to contain
biologically active components such as non-collagenous glycosami-
noglycans, glycoproteins, and growth factors that act as a tissue
“template” following placement, directing the patient’s ﬁbro-
blasts to synthesize new connective tissue that is “programmed”
by the implant [12–14]. Additionally, SIS has been shown in several
previous animal experiments to be relatively non-adhesiogenic. For
example, Clark et al. [15] demonstrated that adhesions formed by
SIS in a dog model of abdominal wall repair were much less ex-
tensive and less tenacious than those adhesions induced by uncoated
polypropylene. These ﬁndings were supported by Scalco et al. [16]
and Konstantinovic et al. [17] in rat experiments.
Ansaloni et al. [18] were the ﬁrst to demonstrate in principle that
polypropylene mesh protected by SIS decreases the adhesiogenic
Fig. 2. Tissue response to Ventralight ST in the rat after 3 weeks. Histological (H&E)
analysis shows inﬂammatory cells directed toward the adhesion-resistant coating
as well as signiﬁcant ﬁbrovascular tissue deposition around the implant. Bar = 100 μm.
Fig. 3. Tissue response to Prolene in the rat after 3 weeks. Histology (H&E) shows
only minimal amounts of tissue deposition with some inﬂammation immediately
around the polypropylene ﬁbers. Bar = 100 μm.
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nature of uncoated polypropylene. They hypothesized that the rapid
cellular inﬁltration, followed by neovascularization, and replace-
ment of the acellular matrix with well-organized site-speciﬁc tissue
reduces the potential for adhesions to form post-surgery. Addition-
al mechanisms of anti-adhesion formationmay include a less robust
direct inﬂammatory reaction against the mesh, as well as the pos-
siblemodulation of macrophage phenotype as a result of the addition
of an intact ECM layer [19].
The data presented here are comparison of Zenapro to coated
and uncoated polypropylene in two different animal species, and
while in agreement, the applicability of these results to humans has
not been veriﬁed. There was little inﬂammation and robust colla-
gen deposition observed in the Zenapro samples in both experiments.
Additionally, the comparators demonstratedmore inﬂammation, and
in the case of the uncoated polypropylene, little collagen deposi-
tion. While the Zenapro device appeared to induce the formation
and deposition of organized ﬁbrous connective tissue around the
polypropylene component of the device in the rabbit model, the
Ventralight ST device failed to promote such a robust deposition of
collagen along the peritoneal surface of the implant. A signiﬁcant
limitation to the rabbit study is the small number of animals used
in the experiment, so these ﬁrst observations need to be con-
ﬁrmed in a greater number of animals.
In the search for the ideal mesh for repairing primary fascial
defects, the Zenapro Hybrid Hernia Repair Device is a step toward
the solution. By combining a complete ECMwith a synthetic mesh,
tissue remodeling, neovascularization and tissue ingrowth are
enhanced, high tensile strength is maintained, and, as shown here,
adhesiogenic effects are mitigated.
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Fig. 4. Direct histological comparison of collagen deposition in the rat. Trichrome staining suggests that collagen accumulation was greatest for the Zenapro implants (a) as
compared to either the Ventralight ST (b) or Prolene implants (c). Bars = 100 μm.
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